Market news

Agreement Covers Key Southern California Counties Including Los Angeles Metro as NeuroOne Broadens Commercial Access in Key U.S. MarketsEDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on transforming the surgical diagnosis and treatment of neurological disorders, today announced a new Southern California distribution agreement for its FDA-cleared OneRF® Trigeminal

Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED(TM) Platform for Human Investigational Clinical Studies Later This Quarter Related StereoCED(TM) Revenue Expected to be Recognized in the Current Fiscal Quarter ...

Detailed price information for Neuroone Medical Technologies Corp (NMTC-Q) from The Globe and Mail including charting and trades.

Moby summary of NeuroOne Medical Technologies Corporation's Q3 2026 earnings call

$2.7 Million in Product Orders Outpace Shipments of $2.0 Million Company Has Received Product Orders for Fiscal Year 2026 of $11.2 Million; Working with Suppliers to Maximize Product Shipments Through End of Fiscal Year Received ISO 13485 Certifica...

EDEN PRAIRIE, MINN. - August 3, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological ...

White Paper Highlights How StereoCED(TM) is Designed to Address Key Barriers to the Scalable Commercial Delivery of Brain Therapeutics Through a Streamlined Robotic-Assisted Workflow Device Availability for Research and Investigational Clinical Studi...

Large, Single-Center Patient Cohort Demonstrates Meaningful Reductions in Seizure Frequency and Severity, While Improving Patient Quality of Life* Growing Real-World Evidence Demonstrates an Emerging Diagnosis-to-Therapy Paradigm through the OneRF(R)...

Detailed price information for Herbalife Ltd (HLF-N) from The Globe and Mail including charting and trades.

Growing Interest From Leading Academic Investigators and Biopharmaceutical Companies in NeuroOne's Drug Delivery Platform EDEN PRAIRIE, MINN. - July 16, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the...